Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting

de, Oliveira Ferreira Anderson; Holandino, Carla

Abstract

Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting

Author(s): de Oliveira Ferreira Anderson, Holandino Carla

Issue: Mar/Apr 2008 - Compounding Around the World

View All Articles in Issue

Page(s): 163-169

Download in electronic PDF format for $75

Abstract

Enteric coated capsules are characterized by their resistance to dissolution in low pH environments, such as the stomach, and by their rapid disintegration in a higher pH environment, such as the intestine. The surface of hard gelatin capsules is usually smooth and nonporous, which limits their coating efficiency. We developed a simple, quick, and easily reproducible compounding preparation method for enteric-release hard gelatin capsules. Twenty-two batches of 60 diclofenac sodium capsules each were prepared and then divided into three groups. Each group was submitted to a different coating process using a small-scale enteric coating machine and a coating process based on the atomization (spraying) of organic solutions of polymers. The results of dissolution testing were compared statistically within the groups and also with a reference drug control (Voltaren DR). Some of the batches in group I and all the batches in groups II and III met the pharmacopeial requirements for enteric release, in both acid and p

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2008 Pg. 163-169	Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting Author(s): de Oliveira Ferreira Anderson, Holandino Carla
Jul/Aug 1999 Pg. 291-294	The Basics of Compounding: Compounding Special Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 209-214	Basics of Compounding: Special Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2001 Pg. 401-405	Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Jul/Aug 2022 Pg. 283-291	Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules Author(s): de Oliveira Ferreira Anderson, Polonini Hudson
Mar/Apr 2009 Pg. 170-174	Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule Author(s): Haywood Alison, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross
Sep/Oct 1999 Pg. 396	Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 312-313	Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 40-41	Rule of Sixes for Filling Hard-Shell Gelatin Capsules Author(s): Nash Robert A
May/Jun 1997 Pg. 187	Triple Estrogen 2.5-mg Semisolid-Filled Hard-Gelatin Capsules Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 232-233	Standard Operating Procedure for Quality Assessment of Powder-Filled, Hard-Gelatin Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 10-22	Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Author(s): Zur Eyal
Mar/Apr 2005 Pg. 157-164	In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride Author(s): Glowiak Dana L, Green Julie L, Bowman Bill J
Sep/Oct 1999 Pg. 409-411	In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Author(s): Webster Kathy D, Al-Achi Antoine, Greenwood Robert
Sep/Oct 2012 Pg. 434-437	Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Author(s): Radojkovic Branko, Milic Jela, Calija Bojan
Sep/Oct 2021 Pg. 364-371	Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Sep/Oct 2023 Pg. 431-439	The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet Author(s): Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Nov/Dec 2008 Pg. 545	Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 547	Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr